In this blog post, we’ll explore why the human body cannot regenerate completely and how regenerative medicine and animal testing are helping to overcome these limitations.
Humans cannot regenerate body parts—such as fingers or noses severed in an accident—exactly as they were originally. Such physical losses are not merely cosmetic issues; they lead to functional impairments that cause significant inconvenience in daily life. Furthermore, these losses often result in psychological trauma, frequently leading to feelings of social isolation or depression. Consequently, people who have lost body parts urgently need treatments that can restore the damaged areas. However, despite significant advances in certain areas of tissue reconstruction and organ transplantation, current medical technology has not yet reached the stage where lost body parts can be fully restored to their original state.
Many patients suffering from end-stage organ disease lose their lives because they cannot receive the necessary organ transplants in time. There remains an acute shortage of organ donors, and organ transplant waiting lists in every country are filled with countless patients. As a result, patients and their families must wait for a transplant opportunity for long periods, enduring anxiety and despair. To address these issues, the medical community is actively researching regenerative medicine technologies such as artificial organs, stem cell therapy, tissue engineering, and 3D bioprinting. While some of these technologies are already being applied clinically, technical and ethical challenges remain to be resolved before they can fully replace most complex organs. To overcome these limitations, many biotechnologists and chemical and biological engineers are working tirelessly every day to develop new treatments.
As a prime example, Charles Vacanti and his research team at the MIT Medical Center conducted a study using tissue engineering techniques to grow cartilage tissue inside the bodies of living animals. In this study, they successfully cultured cartilage cells on a biodegradable scaffold and transplanted them into immunodeficient mice, resulting in the formation of ear-shaped cartilage tissue. Although the photos released at the time appeared to show a human ear growing, it was actually not a human ear itself but ear-shaped cartilage tissue. This study is regarded as a landmark achievement that demonstrated the potential of tissue engineering to the world.
The cartilage that makes up the ear is extremely difficult to fully restore to its original state when damaged by congenital malformations or accidents. Consequently, many researchers, including Charles Vacanti’s team, have been studying methods to grow cartilage tissue in a living environment. Such research is regarded as a crucial foundation for the future development of regenerative medicine, going beyond mere scientific curiosity. This is because if damaged tissue can be regenerated using the patient’s own cells, the potential to restore not only ears but also various other tissues and organs in the future will greatly increase. The laboratory mice that became famous through this research are commonly referred to as “Vacanti mice.”
